ArticleActa pharmaceutica Sinica. B2022

Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.